US FDA to spend $2.5 billion on IT modernisation
This article was originally published in Scrip
Executive Summary
The US FDAwill award 10 contractors up to a total of $2.5 billion for information technology and data centre management services over the next 10 years. The agency says the contracts are the cornerstone of its IT modernisation programme encompassing data management, data warehousing, IT infrastructure and security. "This contract sets the stage for the FDA to have IT to acquire, analyse and act on data critical for import protection, food protection and medical product safety plans," FDA commissioner Dr Andrew von Eschenbach said. The FDA's IT infrastructure has been widely criticised as inadequate and outdated for the agency's functions, particularly its ability to oversee foreign drug manufacturers.
You may also be interested in...
Rare Diseases: CBER Looks To ‘Lean Into’ Accelerated Approval, Align More With CDER
US FDA biologics center officials spoke about their efforts to increase collaboration and harmonization with the drugs center, and to internally involve more review disciplines in evaluating biomarker evidence, during a Reagan-Udall Foundation meeting that weighed potential use of accelerated approval for neuronopathic mucopolysaccharidoses disorders.
RWE: Non-Interventional Studies Must Be Able To Distinguish A True Treatment Effect, US FDA Says
Agency describes a host of issues sponsors should consider and address before pursuing observational or case-control studies to support regulatory decision-making on drug efficacy or safety; new draft guidance was issued under the FDA’s Real-World Evidence program.
Eye On ODAC: Former Members, FDA’s Pazdur Talk Pre-Meeting Mindsets, Impact Of Sponsor’s Experts
Oncologic Drugs Advisory Committee reps and the Oncology Center of Excellence director go behind the scenes to discuss FDA interactions with panelists, how opinions can change during a meeting, and why the voting question is important.